Aeterna Zentaris is an oncology and endocrinology drug development company that is presently investigating treatments for a variety of unmet medical needs. The company’s product pipeline consists of compounds at all stages of development – from drug discovery to marketed products. The company’s lead drug development candidates include Perifosine, AEZS-108 and AEZS-130. For more information, visit the company’s Web site: http://www.aezsinc.com
Let us hear your thoughts below: